Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells. [electronic resource]
Producer: 20131112Description: 1625-35 p. digitalISSN:- 1432-1335
- Antibiotics, Antineoplastic -- pharmacology
- Benzamides -- pharmacology
- Cell Death -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Doxorubicin -- pharmacology
- Drug Resistance, Neoplasm
- Female
- Humans
- I-kappa B Proteins -- metabolism
- Imatinib Mesylate
- Kinetics
- NF-KappaB Inhibitor alpha
- NF-kappa B -- metabolism
- Phosphorylation
- Piperazines -- pharmacology
- Protein Binding
- Protein Kinase Inhibitors -- pharmacology
- Protein Processing, Post-Translational -- drug effects
- Proteolysis
- Proto-Oncogene Proteins c-abl -- antagonists & inhibitors
- Pyrimidines -- pharmacology
- Transcriptional Activation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.